Clinical Trial Update: Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous stem cell transplantation in systemic sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Interstitial Lung Disease
• Pulmonary Hypertension
• Systemic Sclerosis

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)

Snippet

Sponsor: Paul Szabolcs | Conditions: Systemic Sclerosis, Diffuse Sclerosis Systemic | Phase 2 | Status: RECRUITING